Modality: MRI (T2)

- “ Pseudoprogression is typically encountered in the first 6 months following completion of radiotherapy and is particularly common in MGMT methylate...”

View full size version of Glioblastoma IDH wild-type (thalamic with pseudoprogression)

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.